BIOMERICA INC — Form 10-K
Filed August 31, 2026 · analyzed by the Periodic Agent
10-K
— Neutral
significance 52/100
What the filing says
Biomerica's Board and stockholders approved an amendment to the Certificate of Incorporation on December 12, 2025, increasing authorized common stock from an unspecified prior amount to 300,000,000 shares (par value $0.08). Total authorized shares increased to 305,000,000 (300M common + 5M preferred). The amendment was executed by CEO Zackary S. Irani on June 10, 2025. No share issuance occurred in this action—only an increase in authorized capacity.
Why this rating
Authorization increase is administrative; significance depends on actual dilution. Neutral pending capital raise announcement. Company faces going-concern doubt per auditor.
See more from August 31, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.